Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

Anjali suffered intense eye pain for months. Doctors found her eyes healthy. Neurologist Dr Sudhir Kumar diagnosed migraine. Migraines can ...

Childhood migraines are often missed, as seen with 10-year-old Anush, who suffered for months with recurring headaches and abdominal pain, ...

In a significant breakthrough for migraine sufferers in India, Pfizer has launched Rimegepant ODT, an innovative oral tablet that dissolves...

Alembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatripta...

Ayurveda takes a holistic approach to migraine relief by addressing the root cause: an imbalanced Pitta dosha. Dietary adjustments, cooling...

The research employed a non-invasive imaging technique called optical coherence tomography angiography (OCTA) to observe alterations in ret...

Hyderabad-based pharmaceutical company, Dr Reddy's Laboratories, has launched Nerivio, a revolutionary wearable therapy device for the trea...

Dr Reddy's Laboratories has introduced Nerivio, a wearable therapy device for drug-free migraine management, approved by the US FDA. Nerivi...

A press release from Theranica on Tuesday said under the terms of the agreement, Dr. Reddy's will be responsible for the regulatory approva...

Genetics and environmental factors play a role in the condition of migraine.

Sleeping later than your normal hours during weekends often causes a 'let-down' headache.

Dr Reddy's Laboratories (DRL) today said its acute migraine treatment injection ZembraceSymTouch is now commercially available in the US ma...

The company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...

Jubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.

The government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...